Uptake and intracellular release kinetics of liposome formulations in glioma cells

International Journal of Pharmaceutics

Volumn 395, Issue 1-2, 2010, Pages 251-259

  Bellavance, Marc André ^a   Poirier, Marie Belle ^b   Fortin, David ^b  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

Blood brain barrier; Cationic liposomes; Glioblastoma; PEG; PH responsive

Indexed keywords

3BETA [N (N',N' DIMETHYLAMINOETHANE)CARBAMOYL]CHOLESTEROL; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; DISTEAROYLPHOSPHATIDYLCHOLINE; LIPOSOME; MACROGOL 2000; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; 1,2-DIDODECANOYL-GLYCERO-3-PHOSPHOCHOLINE; 1,2-DIOLEOYL-GLYCERO-3-PHOSPHATIDYL ETHANOLAMINE; 3-(N-(N',N'-DIMETHYLAMINOETHANE)CARBAMOYL)CHOLESTEROL; CARBOXYLIC ACID; CHOLESTEROL; DPPE-PEG2000; MACROGOL DERIVATIVE; OREGON GREEN 488 CARBOXYLIC ACID; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; FLOW CYTOMETRY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; LIPID COMPOSITION; MEMBRANE FLUIDITY; NONHUMAN; PRIORITY JOURNAL; RAT; ANALOGS AND DERIVATIVES; ANIMAL; BRAIN TUMOR; GLIOMA; KINETICS; LIPID METABOLISM; MEDICINAL CHEMISTRY; METABOLISM; PARTICLE SIZE; PH; TRANSMISSION ELECTRON MICROSCOPY; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANIMALS; BIOLOGICAL TRANSPORT; BRAIN NEOPLASMS; CARBOXYLIC ACIDS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; FLOW CYTOMETRY; GLIOMA; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; LIPID METABOLISM; LIPOSOMES; MEMBRANE FLUIDITY; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLGLYCEROLS; POLYETHYLENE GLYCOLS; RATS;

EID: 77954314423     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.05.017     Document Type: Article

References (62)

1. Abbott N., Ronnback L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006, 7:41-53.
2. Bailey A.L., Cullis P.R. Membrane fusion with cationic liposomes: effects of target membrane lipid composition. Biochemistry 1997, 36:1628-1634.
3. Bangham A.D., Standish M.M., Watkins J.C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 1965, 13:238-252.
4. Barth R.F., Kaur B. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. J. Neurooncol. 2009, 94:299-312.
5. Bartsch M., Weeke-Klimp A.H., Meijer D.K.F., Scherphof G.L., Kamps J.A.A.M. Cell-specific targeting of lipid-based carriers for ODN and DNA. J. Liposome Res. 2005, 15:59-92.
6. Begley D.J. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol. Ther. 2004, 104:29-45.
7. Béduneau A., Saulnier P., Benoit J.-P. Active targeting of brain tumors using nanocarriers. Biomaterials 2007, 28:4947-4967.
8. Blanchette M., Pellerin M., Tremblay L., Lepage M., Fortin D. Real-time monitoring of gadolinium diethylenetriamine penta-acetic acid during osmotic blood-brain barrier disruption using magnetic resonance imaging in normal wistar rats. Neurosurgery 2009, 65:344-350.
9. de Boer A., Gaillard P. Drug targeting to the brain. Annu. Rev. Pharmacol. Toxicol. 2007, 47:323-355.
10. Bondy M.L., Scheurer M.E., Malmer B., Barnholtz-Sloan J.S., Davis F.G., Il'yasova D., Kruchko C., McCarthy B.J., Rajaraman P., Schwartzbaum J.A., Sadetzki S., Schlehofer B., Tihan T., Wiemels J.L., Wrensch M., Buffler P.A., Consortium B.T.E. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008, 113:1953-1968.
11. Brasnjevic I., Steinbusch H.W.M., Schmitz C., Martinez-Martinez P., Initiative E.N.R. Delivery of peptide and protein drugs over the blood-brain barrier. Prog. Neurobiol. 2009, 87:212-251.
12. Calatozzolo C., Gelati M., Ciusani E., Sciacca F.L., Pollo B., Cajola L., Marras C., Silvani A., Vitellaro-Zuccarello L., Croci D., Boiardi A., Salmaggi A. Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma. J. Neurooncol. 2005, 74:113-121.
13. Cecchelli R., Berezowski V., Lundquist S., Culot M., Renftel M., Dehouck M.-P., Fenart L. Modelling of the blood-brain barrier in drug discovery and development. Nat. Rev. Drug Discov. 2007, 6:650-661.
14. Charest G., Paquette B., Fortin D., Mathieu D., Sanche L. Concomitant treatment of F98 glioma cells with new liposomal platinum compounds and ionizing radiation. J. Neurooncol. 2009, 87:187-193.
15. Chen Y., Dalwadi G., Benson H.A.E. Drug delivery across the blood-brain barrier. Curr. Drug Deliv. 2004, 1:361-376.
16. Claes A., Idema A.J., Wesseling P. Diffuse glioma growth: a guerilla war. Acta Neuropathol. 2007, 114:443-458.
17. Correale J., Villa A. Cellular elements of the blood-brain barrier. Neurochem. Res. 2009, 34:2067-2077.
18. DeAngelis L.M. Brain tumors. N. Engl. J. Med. 2001, 344:114-123.
19. Deeken J., Loscher W. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses. Clin. Cancer Res. 2007, 13:1663-1674.
20. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 1999, 51:691-743.
21. Fenske D.B., Cullis P.R. Liposomal nanomedicines. Expert Opin. Drug Deliv. 2008, 5:25-44.
22. Garcia-Garcia E., Andrieux K., Gil S., Couvreur P. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?. Int. J. Pharm. 2005, 298:274-292.
23. Glavinas H., Krajcsi P., Cserepes J., Sarkadi B. The role of ABC transporters in drug resistance, metabolism and toxicity. Curr. Drug Deliv. 2004, 1:27-42.
24. Harrington K.J., Syrigos K.N., Vile R.G. Liposomally targeted cytotoxic drugs for the treatment of cancer. J. Pharm. Pharmacol. 2002, 54:1573-1600.
25. Hart S.L. Lipid carriers for gene therapy. Curr. Drug Deliv. 2005, 2:423-428.
26. Henson J.W., Cordon-Cardo C., Posner J.B. P-glycoprotein expression in brain tumors. J. Neurooncol. 1992, 14:37-43.
27. Hoekstra D., Rejman J., Wasungu L., Shi F., Zuhorn I. Gene delivery by cationic lipids: in and out of an endosome. Biochem. Soc. Trans. 2007, 35:68-71.
28. Huth U.S., Schubert R., Peschka-Süss R. Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bio-imaging. J. Control. Release 2006, 110:490-504.
29. Huwyler J., Drewe J., Krähenbühl S. Tumor targeting using liposomal antineoplastic drugs. Int. J. Nanomed. 2008, 3:21-29.
30. Huynh G.H., Deen D.F., Szoka F.C. Barriers to carrier mediated drug and gene delivery to brain tumors. J. Control. Release 2006, 110:236-259.
31. Kemper E., Boogerd W., Thuis I., Beijnen J., Tellingen O.V. Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?. Cancer Treat. Rev. 2004, 30:415-423.
32. Kobayashi T., Ishida T., Okada Y., Ise S., Harashima H., Kiwada H. Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells. Int. J. Pharm. 2007, 329:94-102.
33. Koo Y.-E.L., Reddy G.R., Bhojani M., Schneider R., Philbert M.A., Rehemtulla A., Ross B.D., Kopelman R. Brain cancer diagnosis and therapy with nanoplatforms. Adv. Drug Deliv. Rev. 2006, 58:1556-1577.
34. Langner M., Kral T.E. Liposome-based drug delivery systems. Pol. J. Pharmacol. 1999, 51:211-222.
35. Lian T., Ho R.J. Trends and developments in liposome drug delivery systems. J. Pharm. Sci. 2001, 90:667-680.
36. Löscher W., Potschka H. Drug resistance in brain diseases and the role of drug efflux transporters. Nat. Rev. Neurosci. 2005, 6:591-602.
37. Mamot C., Drummond D.C., Hong K., Kirpotin D.B., Park J.W. Liposome-based approaches to overcome anticancer drug resistance. Drug Resist. Updat. 2003, 6:271-279.
38. Mathieu D., Lecomte R., Tsanaclis A.M., Larouche A., Fortin D. Standardization and detailed characterization of the syngeneic Fischer/F98 glioma model. Can. J. Neurol. Sci. 2007, 34:296-306.
39. Medina-Kauwe L.K., Xie J., Hamm-Alvarez S. Intracellular trafficking of nonviral vectors. Gene Ther. 2005, 12:1734-1751.
40. Merdan T., Kopecek J., Kissel T. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv. Drug Deliv. Rev. 2002, 54:715-758.
41. Nakada M., Nakada S., Demuth T., Tran N.L., Hoelzinger D.B., Berens M.E. Molecular targets of glioma invasion. Cell. Mol. Life Sci. 2007, 64:458-478.
42. Nakanishi M., Noguchi A. Confocal and probe microscopy to study gene transfection mediated by cationic liposomes with a cationic cholesterol derivative. Adv. Drug Deliv. Rev. 2001, 52:197-207.
43. O'Byrne K.J., Thomas A.L., Sharma R.A., DeCatris M., Shields F., Beare S., Steward W.P. A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer. Br. J. Cancer 2002, 87:15-20.
44. Pardridge W. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2005, 2:3-14.
45. Pardridge W.M. Drug targeting to the brain. Pharm. Res. 2007, 24:1733-1744.
46. Pinto-Alphandary H., Andremont A., Couvreur P. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. Int. J. Antimicrob. Agents 2000, 13:155-168.
47. Rich J.N., Bigner D.D. Development of novel targeted therapies in the treatment of malignant glioma. Nat. Rev. Drug Discov. 2004, 3:430-446.
48. Salvati A., Ciani L., Ristori S., Martini G., Masi A., Arcangeli A. Physico-chemical characterization and transfection efficacy of cationic liposomes containing the pEGFP plasmid. Biophys. Chem. 2006, 121:21-29.
49. Sapra P., Tyagi P., Allen T.M. Ligand-targeted liposomes for cancer treatment. Curr. Drug Deliv. 2005, 2:369-381.
50. Sharma U.S., Sharma A., Chau R.I., Straubinger R.M. Liposome-mediated therapy of intracranial brain tumors in a rat model. Pharm. Res. 1997, 14:992-998.
51. Shi F., Wasungu L., Nomden A., Stuart M.C., Polushkin E., Engberts J.B., Hoekstra D. Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions. Biochem. J. 2002, 366:333-341.
52. Stupp R., Mason W.P., Bent M.J.V.D., Weller M., Fisher B., Taphoorn M.J.B., Belanger K., Brandes A.A., Marosi C., Bogdahn U., Curschmann J., Janzer R.C., Ludwin S.K., Gorlia T., Allgeier A., Lacombe D., Cairncross J.G., Eisenhauer E., Mirimanoff R.O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352:987-996. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group.
53. Szakács G., Paterson J.K., Ludwig J.A., Booth-Genthe C., Gottesman M.M. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 2006, 5:219-234.
54. Tiwari S.B., Amiji M.M. A review of nanocarrier-based CNS delivery systems. Curr. Drug Deliv. 2006, 3:219-232.
55. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 2005, 4:145-160.
56. Uchiyama K., Nagayasu A., Yamagiwa Y., Nishida T., Harashima H., Kiwada H. Effects of the size and fluidity of liposomes on their accumulation in tumors: a presumption of their interaction with tumors. Int. J. Pharm. 1995, 121:195-203.
57. Vescovi A.L., Galli R., Reynolds B.A. Brain tumour stem cells. Nat. Rev. Cancer 2006, 6:425-436.
58. Wasungu L., Hoekstra D. Cationic lipids, lipoplexes and intracellular delivery of genes. J. Control. Release 2006, 116:255-264.
59. Waterhouse D.N., Madden T.D., Cullis P.R., Bally M.B., Mayer L.D., Webb M.S. Preparation, characterization, and biological analysis of liposomal formulations of vincristine. Methods Enzymol. 2005, 391:40-57.
60. Wen P.Y., Kesari S. Malignant gliomas in adults. N. Engl. J. Med. 2008, 359:492-507.
61. Wolburg H., Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul. Pharmacol. 2002, 38:323-337.
62. Xu Y., Szoka F.C. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 1996, 35:5616-5623.